Posts by
CFA’s prediction that Medicare would inevitably initiate mandatory bundled payment for cardiac procedures, has come to pass more quickly than even we imagined. On July 25th, HHS published their Notice of Proposed Rulemaking for Bundled Payment Models for High-Quality, Coordinated Cardiac and Hip Fracture Care.
Is TAVR1 suitable for everyone? As originally approved, transcatheter aortic valve replacement was intended only for high risk patients who could not otherwise endure an open-surgical (or sAVR) procedure; the selection criteria was strict.
It’s easy to take the congenital heart defect population for granted. It constitutes only a relatively small portion of those impacted by cardiovascular disease and has historically consisted predominantly of children born with inherited defects.
As if the writing was not already on the wall, there is further evidence that HHS will inevitably initiate bundled payment for select cardiac procedures.
An important Perspective article was published in the New England Journal of Medicine by Michael Porter and Dr. Thomas Lee entitled, “Why Strategy Matters Now.”(1)
An important Perspective article was published in the New England Journal of Medicine by Michael Porter and Dr. Thomas Lee entitled, “Why Strategy Matters Now.” (1) Their p
What does marketing strategy have to tell us about maintaining or defending a service in a declining or mature market? In essence, quite a lot. For the cardiovascular administrator, there are CV sub-markets in ascension, and there are also those in decline.
Much is being written these days on patient experience as a critical part of the value equation (value defined as patient safety, quality outcomes and patient experience divided by cost/price point).
When reviewing healthcare statistics, there is usually both good and bad news. However, looking at the National Center for Health Statistics deaths from heart disease for 2010-2013, there is mostly good news to report. Death rates per 100,000 population (see table) are trending down for Whites, Blacks and Hispanics. That’s the good news.
The bad news is that there are still heart disease disparities between ethnicities when it comes to both incidence and rates of decline.
Over the past several years, the diagnosis and endovascular treatment of peripheral vascular disease has increased significantly in many hospitals.
